These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Ultrastructural changes on clinical isolates of Trichophyton rubrum, Trichophyton mentagrophytes, and Microsporum gypseum caused by Solanum chrysotrichum saponin SC-2. López-Villegas EO, Herrera-Arellano A, de Los Angeles Martínez-Rivera M, Alvarez L, Cano-Nepauseno M, Marquina S, Rodríguez-Tovar AV, Tortoriello J. Planta Med; 2009 Nov; 75(14):1517-20. PubMed ID: 19551614 [Abstract] [Full Text] [Related]
43. A pilot study on seborrheic dermatitis using pramiconazole as a potent oral anti-Malassezia agent. Piérard GE, Ausma J, Henry F, Vroome V, Wouters L, Borgers M, Cauwenbergh G, Piérard-Franchimont C. Dermatology; 2007 Nov; 214(2):162-9. PubMed ID: 17341867 [Abstract] [Full Text] [Related]
44. Tinea capitis caused by Microsporum canis treated with terbinafine. Aste N, Pau M. Mycoses; 2004 Oct; 47(9-10):428-30. PubMed ID: 15504128 [Abstract] [Full Text] [Related]
45. Efficacy and safety of a new single-dose terbinafine 1% formulation in patients with tinea pedis (athlete's foot): a randomized, double-blind, placebo-controlled study. Ortonne JP, Korting HC, Viguié-Vallanet C, Larnier C, Savaluny E. J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1307-13. PubMed ID: 17062050 [Abstract] [Full Text] [Related]
46. [Characterization of species of the gender Malassezia in patients with seborrheic dermatitis and subjects without skin lesions]. Rendic E, Díaz C, Fich F. Rev Med Chil; 2003 Nov; 131(11):1295-300. PubMed ID: 14743691 [Abstract] [Full Text] [Related]
47. Toxicology, genotoxicity, and cytotoxicity of three extracts of Solanum chrysotrichum. Aguilar-Santamaría L, Herrera-Arellano A, Zamilpa A, Alonso-Cortés D, Jiménez-Ferrer E, Tortoriello J, Zúñiga-González G. J Ethnopharmacol; 2013 Oct 28; 150(1):275-9. PubMed ID: 24001890 [Abstract] [Full Text] [Related]
48. Can pityriasis versicolor be treated with 2% ketoconazole foam? Cantrell WC, Elewksi BE. J Drugs Dermatol; 2014 Jul 28; 13(7):855-9. PubMed ID: 25007370 [Abstract] [Full Text] [Related]
52. Successful treatment and prophylaxis of scalp seborrhoeic dermatitis and dandruff with 2% ketoconazole shampoo: results of a multicentre, double-blind, placebo-controlled trial. Peter RU, Richarz-Barthauer U. Br J Dermatol; 1995 Mar 28; 132(3):441-5. PubMed ID: 7718463 [Abstract] [Full Text] [Related]
56. Cutaneous malasseziasis: four case reports of atypical dermatitis and onychomycosis caused by Malassezia. Zhao Y, Li L, Wang JJ, Kang KF, Zhang QQ. Int J Dermatol; 2010 Feb 16; 49(2):141-5. PubMed ID: 20465637 [Abstract] [Full Text] [Related]
58. Efficacy and skin tolerability of saliker in the treatment of dandruff. Schwartz JR. Eur J Dermatol; 2002 Feb 16; 12(6):617. PubMed ID: 12506888 [No Abstract] [Full Text] [Related]
59. In vitro anti-Malassezia activity and potential use in anti-dandruff formulation of Asparagus racemosus. Onlom C, Khanthawong S, Waranuch N, Ingkaninan K. Int J Cosmet Sci; 2014 Feb 16; 36(1):74-8. PubMed ID: 24117781 [Abstract] [Full Text] [Related]
60. Efficacy of a piroctone olamine/climbazol shampoo in comparison with a zinc pyrithione shampoo in subjects with moderate to severe dandruff. Schmidt-Rose T, Braren S, Fölster H, Hillemann T, Oltrogge B, Philipp P, Weets G, Fey S. Int J Cosmet Sci; 2011 Jun 16; 33(3):276-82. PubMed ID: 21272039 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]